Transition Therapeutics (TTHI) Reports Q3 Loss of CDN$0.11/Share
Tweet
Share
E-mailGet Alerts TTHI Hot Sheet
Join SI Premium – FREE
Transition Therapeutics (NASDAQ: TTHI) reported Q3 EPS of (CDN$0.11), versus (CDN$0.13) reported last year.
For earnings history and earnings-related data on Transition Therapeutics (TTHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
- Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
